The U.S. Food and Drug Administration has approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for patients whose eczema is not controlled adequately...
Read MoreIt has been estimated that more than 80 million people in the world have an unfulfilled desire to have children. But for every 10th couple, the reasons therefor remain unclear....
Read MoreEasyfairs UK & Global has underscored its commitment to CCR Expo, the UK’s largest event for medical aesthetics, with an unrivalled level of investment for the 2017 show. CCR Expo,...
Read MoreCombination of innovative aesthetic technology and proven patient marketing increases revenue from repeat business and reduces equipment payoff time eRelevance Corporation, the leading tech-powered marketing automation service...
Read MoreA survey of over 1000 women living in South East England has revealed that nearly 30% believe that stress and anxiety has had the most significant impact on how much...
Read MorePRIME previews the 15th Facial Aesthetic Conference & Exhibition (FACE 2017), taking place in London on 16–18 June 2017 EuroMediCom and Informa are delighted to invite you to FACE 2017 — the...
Read MorePRIME previews the AMEC Live & Visage 2017 joint meeting, taking place in Monaco on 15–17 September preceded by One2One private training on 14 September 2017 Euromedicom and informa are...
Read MoreBrian S. Biesman and Molly E. Katz discuss their comprehensive approach to treating acne scars, including boxcar, atrophic, and pitted subtypes Acne scarring is a source of great distress and...
Read More